# Codex Review: medical_monitoring_phase_b3_mapping_dryrun_20260801

Date: 2026-08-01 23:24 CST
Execution: Codex direct; no Hermes route, conference, or sub-agent was used.
Changed source/test/evidence:
- `services/api/app/medical_risk_mapping.py`
- `tests/test_medical_risk_mapping.py`
- `runs/execution/medical_monitoring_phase_b3_mapping_dryrun_20260801/run_mapping_dryrun.py`
- `runs/execution/medical_monitoring_phase_b3_mapping_dryrun_20260801/MAPPING_REVIEW_AND_DRYRUN.json`

## Verdict

**Pass for the non-writing B3 mapping-candidate and in-memory dry-run slice; no mapping was approved and Phase B migration remains blocked.**

## Boundary Check

- The A6 clone was opened read-only; remapping used Pydantic deep copies in memory only.
- All five candidates are explicit `approved=false`, `write_permitted=false` and
  `review_required=true`.
- No runtime database, migration schema, service, router, frontend, medical-writing
  path, or frozen v9-v12 job was changed; 8911/5174 remained stopped and 18911 was not touched.

## Codex Verification

- Mapping focused tests: **4 passed**.
- B1+B2+B3 plus existing risk compatibility set: **108 passed, 17 warnings**.
- `python3 -m py_compile` and `python3 -m ruff check` for mapping source, tests and
  dry-run script: passed.
- Actual clone candidates: five unique high-confidence `exact_risk_id` candidates:
  three MY009 records map to current `riskinst_59415fce46bfdc15`, and two RUX records
  map to current `riskinst_398048314441ba73`. These are proposals only.
- In-memory dry-run after applying those candidate identities: 2 dispositions matched;
  4 blockers remain (three MY009 source-version mismatches and one aggregate-state
  drift for the submitted-for-approval chain), `migration_ready=false`.
- Evidence:
  `runs/execution/medical_monitoring_phase_b3_mapping_dryrun_20260801/MAPPING_REVIEW_AND_DRYRUN.json`
  with dry-run report hash `c7af4abf41a659a2385141b66c37f0115677986274f4819f98d2a13d9c7b7fa2`.

## Direct Work Review

- Candidate selection uses only project-scoped exact legacy `risk_id`, exact `risk_key`,
  or an explicitly marked item-id suffix fallback; ambiguous and no-candidate paths do
  not guess.
- The dry-run keeps the source record unchanged and does not turn candidate confidence
  into approval. The residual report is routed through the B2 reconciler, so source
  version and aggregate state remain independent blockers.
- The result is a migration review input, not a medical conclusion and not an authority
  write. It does not claim the five mappings are acceptable for production.

## Residual Risk

- The five identity candidates still require explicit medical/engineering review,
  particularly the MY009 source-version change and the RUX risk-instance replacement.
- The B3 dry-run does not test runtime persistence, restart, rollback, authorization,
  deep links, or frontend projections; those require a later controlled migration task.
- Until residual blockers are resolved and approved, no dual-read promotion or write
  migration is authorized.
